BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 25416141)

  • 1. Cannabinoid receptor type-2 stimulation, blockade, and deletion alter the vascular inflammatory responses to traumatic brain injury.
    Amenta PS; Jallo JI; Tuma RF; Hooper DC; Elliott MB
    J Neuroinflammation; 2014 Nov; 11():191. PubMed ID: 25416141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage/microglial activation concomitant to neuroprotection.
    Zarruk JG; Fernández-López D; García-Yébenes I; García-Gutiérrez MS; Vivancos J; Nombela F; Torres M; Burguete MC; Manzanares J; Lizasoain I; Moro MA
    Stroke; 2012 Jan; 43(1):211-9. PubMed ID: 22020035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury.
    Amenta PS; Jallo JI; Tuma RF; Elliott MB
    J Neurosci Res; 2012 Dec; 90(12):2293-305. PubMed ID: 22903455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditions.
    Ramirez SH; Haskó J; Skuba A; Fan S; Dykstra H; McCormick R; Reichenbach N; Krizbai I; Mahadevan A; Zhang M; Tuma R; Son YJ; Persidsky Y
    J Neurosci; 2012 Mar; 32(12):4004-16. PubMed ID: 22442067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective activation of cannabinoid receptor-2 reduces neuroinflammation after traumatic brain injury via alternative macrophage polarization.
    Braun M; Khan ZT; Khan MB; Kumar M; Ward A; Achyut BR; Arbab AS; Hess DC; Hoda MN; Baban B; Dhandapani KM; Vaibhav K
    Brain Behav Immun; 2018 Feb; 68():224-237. PubMed ID: 29079445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte Colony-Stimulating Factor Enhances Brain Repair Following Traumatic Brain Injury Without Requiring Activation of Cannabinoid Receptors.
    Song S; Kong X; Borlongan C; Sava V; Sanchez-Ramos J
    Cannabis Cannabinoid Res; 2021; 6(1):48-57. PubMed ID: 33614952
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute effects of a selective cannabinoid-2 receptor agonist on neuroinflammation in a model of traumatic brain injury.
    Elliott MB; Tuma RF; Amenta PS; Barbe MF; Jallo JI
    J Neurotrauma; 2011 Jun; 28(6):973-81. PubMed ID: 21332427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid 2 receptor is a novel anti-inflammatory target in experimental proliferative vitreoretinopathy.
    Szczesniak AM; Porter RF; Toguri JT; Borowska-Fielding J; Gebremeskel S; Siwakoti A; Johnston B; Lehmann C; Kelly ME
    Neuropharmacology; 2017 Feb; 113(Pt B):627-638. PubMed ID: 27569993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Cannabinoid Receptor 2 Agonist Prevents Thrombin-Induced Blood-Brain Barrier Damage via the Inhibition of Microglial Activation and Matrix Metalloproteinase Expression in Rats.
    Li L; Tao Y; Tang J; Chen Q; Yang Y; Feng Z; Chen Y; Yang L; Yang Y; Zhu G; Feng H; Chen Z
    Transl Stroke Res; 2015 Dec; 6(6):467-77. PubMed ID: 26376816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-Dependent Protection of CB2 Receptor Agonist in Stroke.
    Yu SJ; Reiner D; Shen H; Wu KJ; Liu QR; Wang Y
    PLoS One; 2015; 10(7):e0132487. PubMed ID: 26186541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid type 2 receptor stimulation attenuates brain edema by reducing cerebral leukocyte infiltration following subarachnoid hemorrhage in rats.
    Fujii M; Sherchan P; Krafft PR; Rolland WB; Soejima Y; Zhang JH
    J Neurol Sci; 2014 Jul; 342(1-2):101-6. PubMed ID: 24819918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of nitric oxide in the local antiallodynic and antihyperalgesic effects and expression of delta-opioid and cannabinoid-2 receptors during neuropathic pain in mice.
    Hervera A; Negrete R; Leánez S; Martín-Campos J; Pol O
    J Pharmacol Exp Ther; 2010 Sep; 334(3):887-96. PubMed ID: 20498253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xie2-64, a novel CB
    Jordan CJ; Feng ZW; Galaj E; Bi GH; Xue Y; Liang Y; McGuire T; Xie XQ; Xi ZX
    Neuropharmacology; 2020 Oct; 176():108241. PubMed ID: 32712273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid CB2 receptor stimulation attenuates brain edema and neurological deficits in a germinal matrix hemorrhage rat model.
    Tao Y; Tang J; Chen Q; Guo J; Li L; Yang L; Feng H; Zhu G; Chen Z
    Brain Res; 2015 Mar; 1602():127-35. PubMed ID: 25625355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective Cannabinoid 2 Receptor Agonists as Potential Therapeutic Drugs for the Treatment of Endotoxin-Induced Uveitis.
    Porter RF; Szczesniak AM; Toguri JT; Gebremeskel S; Johnston B; Lehmann C; Fingerle J; Rothenhäusler B; Perret C; Rogers-Evans M; Kimbara A; Nettekoven M; Guba W; Grether U; Ullmer C; Kelly MEM
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31540271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced oxidative stress in iNOS-deficient mice after traumatic brain injury: support for a neuroprotective role of iNOS.
    Bayir H; Kagan VE; Borisenko GG; Tyurina YY; Janesko KL; Vagni VA; Billiar TR; Williams DL; Kochanek PM
    J Cereb Blood Flow Metab; 2005 Jun; 25(6):673-84. PubMed ID: 15716856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of rimonabant-like adverse effects of purported CB1R neutral antagonist / CB2R agonist aminoalkylindole derivatives in mice.
    Tai S; Vasiljevik T; Sherwood AM; Eddington S; Wilson CD; Prisinzano TE; Fantegrossi WE
    Drug Alcohol Depend; 2018 Nov; 192():285-293. PubMed ID: 30300803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Versus Pharmacological Assessment of the Role of Cannabinoid Type 2 Receptors in Alcohol Reward-Related Behaviors.
    Powers MS; Breit KR; Chester JA
    Alcohol Clin Exp Res; 2015 Dec; 39(12):2438-46. PubMed ID: 26756798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CB2R agonist JWH-133 attenuates chronic inflammation by restraining M1 macrophage polarization via Nrf2/HO-1 pathway in diet-induced obese mice.
    Wu Q; Ma Y; Liu Y; Wang N; Zhao X; Wen D
    Life Sci; 2020 Nov; 260():118424. PubMed ID: 32949586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid Receptor Type 2 Agonist Attenuates Acute Neurogenic Pulmonary Edema by Preventing Neutrophil Migration after Subarachnoid Hemorrhage in Rats.
    Fujii M; Sherchan P; Soejima Y; Doycheva D; Zhao D; Zhang JH
    Acta Neurochir Suppl; 2016; 121():135-9. PubMed ID: 26463937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.